Soligenix (SNGX) EBT Margin Growth (5y) (2015 - 2024)
Soligenix (SNGX) EBT Margin Growth (5y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -7.00 Mn |
| Mar 31, 2024 | -144,006.00 |
| Dec 31, 2023 | -68,521.00 |
| Sep 30, 2023 | -113,992.00 |
| Jun 30, 2023 | -68,883.00 |
| Mar 31, 2023 | -64,599.00 |
| Dec 31, 2022 | 230,156.00 |
| Sep 30, 2022 | -192,567.00 |
| Jun 30, 2022 | -130,567.00 |
| Mar 31, 2022 | -217,477.00 |
| Dec 31, 2021 | 85,805.00 |
| Sep 30, 2021 | -187,278.00 |
| Jun 30, 2021 | -125,049.00 |
| Mar 31, 2021 | -152,444.00 |
| Sep 30, 2020 | -25,874.00 |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | 73,587.00 |
| Dec 31, 2019 | 106,117.00 |
| Sep 30, 2019 | -10,012.00 |
| Jun 30, 2019 | -7,469.00 |